These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 10188692)

  • 1. Chemotherapy-induced inflammation in seborrheic keratoses mimicking disseminated herpes zoster.
    Williams JV; Helm KF; Long D
    J Am Acad Dermatol; 1999 Apr; 40(4):643-4. PubMed ID: 10188692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy-induced inflammatory seborrheic keratoses in a man with acute myeloid leukemia: a variant of Leser-Trélat sign?
    Lilly E; Granter SR; Haynes HA; Ibrahimi OA
    Cutis; 2012 Nov; 90(5):235-6. PubMed ID: 23270192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammation of seborrheic keratoses caused by cytarabine: a pseudo sign of Leser-Trelat.
    Patton T; Zirwas M; Nieland-Fisher N; Jukic D
    J Drugs Dermatol; 2004; 3(5):565-6. PubMed ID: 15552612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transient eruptive seborrheic keratoses associated with erythrodermic psoriasis and erythrodermic drug eruption: report of two cases.
    Flugman SL; McClain SA; Clark RA
    J Am Acad Dermatol; 2001 Dec; 45(6 Suppl):S212-4. PubMed ID: 11712062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytarabine-induced inflammation in the seborrheic keratoses of Leser-Trélat.
    Kechijian P; Sadick NS; Mariglio J; Schulman P
    Ann Intern Med; 1979 Dec; 91(6):868-9. PubMed ID: 293142
    [No Abstract]   [Full Text] [Related]  

  • 6. The Leser-Trelat sign is a associated with acute myeloid leukemia.
    Yavasoglu I; Kadikoylu G; Bolaman Z
    Ann Hematol; 2011 Mar; 90(3):363. PubMed ID: 20703879
    [No Abstract]   [Full Text] [Related]  

  • 7. Isolated Bilateral Ear and Scalp Rash After Cytarabine Therapy for Acute Myelogenous Leukemia: A Report and Literature Review.
    Waseem H; Henriquez Felipe C; Hashmi AT; Ansar M; Batool A; Saverimuthu A; Kamholz SL
    Am J Ther; 2019; 26(5):e653-e655. PubMed ID: 30418222
    [No Abstract]   [Full Text] [Related]  

  • 8. The sign of Leser-Trélat in a case of adenocarcinoma of the lung.
    Heaphy MR; Millns JL; Schroeter AL
    J Am Acad Dermatol; 2000 Aug; 43(2 Pt 2):386-90. PubMed ID: 10901731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical and histopathological characteristics of early Leser-Trélat syndrome].
    Barth G; Basten O; Rüschoff J; Rompel R
    Hautarzt; 2001 Jul; 52(7):649-52. PubMed ID: 11475649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bullous acral erythema and concomitant pigmentation on the face and occluded skin.
    Ozkaya-Bayazit E; Diz-Küçükkaya R; Akasya E; Büyükbabani N; Oncü S; Pekçelen Y
    J Eur Acad Dermatol Venereol; 2000 Mar; 14(2):139-40. PubMed ID: 10972102
    [No Abstract]   [Full Text] [Related]  

  • 11. Posterior reversible encephalopathy syndrome (PRES) during induction chemotherapy for acute myeloblastic leukemia (AML).
    Battipaglia G; Avilia S; Morelli E; Caranci F; Perna F; Camera A
    Ann Hematol; 2012 Aug; 91(8):1327-8. PubMed ID: 22237936
    [No Abstract]   [Full Text] [Related]  

  • 12. Continuous 24-h monitoring of electrocardiogram during anthracycline-based therapy in acute leukemia.
    Jakl M; Horacek JM; Jebavy L; Pudil R
    Leuk Res; 2009 Aug; 33(8):e109-10. PubMed ID: 19237194
    [No Abstract]   [Full Text] [Related]  

  • 13. Bilateral submandibular salivary gland enlargement during chemotherapy for acute myeloid leukaemia--beneficial effect of propranolol.
    Dabadghao S; Srivastava A; Dennison D
    Acta Haematol; 1996; 96(2):112. PubMed ID: 8701699
    [No Abstract]   [Full Text] [Related]  

  • 14. A phase I trial of continuous infusion of the multidrug resistance inhibitor zosuquidar with daunorubicin and cytarabine in acute myeloid leukemia.
    Lancet JE; Baer MR; Duran GE; List AF; Fielding R; Marcelletti JF; Multani PS; Sikic BI
    Leuk Res; 2009 Aug; 33(8):1055-61. PubMed ID: 19108889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multicenter trial of cytarabine plus idarubicin or daunorubicin as induction therapy for adult nonlymphocytic leukemia.
    Wiernik PH; Case DC; Periman PO; Arlin ZA; Weitberg AB; Ritch PS; Todd MB
    Semin Oncol; 1989 Feb; 16(1 Suppl 2):25-9. PubMed ID: 2928807
    [No Abstract]   [Full Text] [Related]  

  • 16. Neurological complications during treatment of childhood cancer: mind Wernicke encephalopathy.
    La Spina M; Catania R; Lo Nigro L; De Grandi C; Palmucci S; Di Cataldo A
    Pediatr Hematol Oncol; 2010 May; 27(4):320-3. PubMed ID: 20426524
    [No Abstract]   [Full Text] [Related]  

  • 17. Sign of Leser-Trélat.
    Schwartz RA
    J Am Acad Dermatol; 1996 Jul; 35(1):88-95. PubMed ID: 8682971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors and short-term outcomes of hyperleukocytosis in children with acute myeloid leukemia: a report from the Children's Oncology Group.
    Sung L; Aplenc R; Alonzo TA; Gerbing RB; Gamis AS;
    Haematologica; 2012 Nov; 97(11):1770-3. PubMed ID: 22801969
    [No Abstract]   [Full Text] [Related]  

  • 19. [Liposomal daunorubicine combined with cytarabine in the treatment of relapsed/refractory acute myeloid leukemia in children].
    Reinhardt D; Hempel G; Fleischhack G; Schulz A; Boos J; Creutzig U
    Klin Padiatr; 2002; 214(4):188-94. PubMed ID: 12165900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Favorable outcome in a patient with vulvar mucormycosis during acute myeloid leukemia induction with medical management alone.
    Udupa K; Ganesan P; Majhi U; Rajendranath R; Sagar TG
    Hematol Oncol Stem Cell Ther; 2012; 5(2):125-6. PubMed ID: 22828378
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.